Activities, Bill Numbers and Titles
|
|
Client: Pharmaceutical Research and Manufacturers of America (PhRMA)
|
|
Senate Bill
|
2305
|
An Act making appropriations for the fiscal year 2017 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for
certain permanent improvements
|
Neutral
|
$934.70
|
N/A
|
House Bill
|
4201
|
An Act making appropriations for the fiscal year 2017 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements
|
Neutral
|
$186.94
|
N/A
|
Senate Bill
|
1042
|
An Act relative to responsible stewardship by drug manufacturers
|
Oppose
|
$186.94
|
N/A
|
Senate Bill
|
1048
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Oppose
|
$11,216.40
|
N/A
|
House Bill
|
4056
|
An Act relative to substance use, treatment, education and prevention
|
Neutral
|
$1,869.40
|
N/A
|
Senate Bill
|
1186
|
An Act to Restore Integrity in the Marketing of Pharmaceutical Products and Medical Devices
|
Oppose
|
$186.94
|
N/A
|
House Bill
|
2059
|
An Act establishing a statewide discount program for pharmaceuticals
|
Oppose
|
$186.94
|
N/A
|
| | |
Total amount
|
$14,768.26
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
No campaign contributions were filed for this disclosure reporting period. |
|